Eremenko 2008.
Methods | Randomized, blinded, placebo‐controlled Medications administered 30 min before extubation |
|
Participants | Type of surgery: coronary bypass surgery Paracetamol group Entered/completing: 22/? Age (mean, SD): unclear Sex (male, %): 77 Placebo group Entered/completing: 23/? Age (mean, SD): unclear Sex (male, %): 73 |
|
Interventions | Intervention: paracetamol 1 g/100 ml IV (every 6 h x 4 doses) Placebo: 100 ml normal saline |
|
Outcomes | Inspiratory volume Pain intensity (VRS) AEs not reported All other outcomes described over duration of study (18 h) |
|
Source of funding | Not reported | |
Were treatment groups comparable at baseline? | Yes: demographics | |
Details of preoperative pain | Not reported | |
Notes | Russian language study | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Computer‐generated |
Allocation concealment (selection bias) | Unclear risk | Not described |
Blinding (performance bias and detection bias) All outcomes | Unclear risk | Described as blinded, but no mention of whether single‐ or double‐blinded |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Not described |
Selective reporting (reporting bias) | Unclear risk | Not described |
Size | High risk | Fewer than 50 participants per arm of the study (22 paracetamol, 23 placebo) |